New home-use glucometer delivers results in under 10 seconds with simplified testing, large memory storage, and user-friendly design
_256_384.jpg)
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
Clinical guidelines and expert consensus recommend 1.2–1.5 g/kg/day protein intake during therapy to help preserve muscle mass
New policy aims to standardise screening, diagnosis and lifelong care for children with diabetes across India’s public health system
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
UBT251 appeared to have a safe and well-tolerated profile consistent with incretin-based therapies
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
The Phase III programme, Enith1 and Enith2, is expected to launch this quarter
The trial’s primary endpoint is the mean change in HbA1c from baseline, while secondary endpoints include changes in fasting blood glucose, body weight, and overall safety
Lupin has bolstered its diabetes and obesity portfolios by securing an agreement for Bofanglutide, a GLP-1 receptor agonist developed by Gan & Lee Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
